Boston—A comprehensive blood management program for orthopedic surgery patients is not only effective in reducing overall blood utilization but is also associated with reduced length of stay (LOS) and readmissions, with no increase in adverse outcomes, a study has concluded.
“One year ago, the AABB [American Association of Blood Banks] released its clinical practice guidelines [JAMA 2016;316[19]:2025-2035], suggesting that patients be transfused at a hemoglobin trigger of 7 g/dL